| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alexis Thompson: advancing care for sickle cell disease
|
Samarasekera, Udani
|
|
|
11 |
5 |
p. e321
|
artikel
|
| 2 |
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study
|
Grover, Natalie S
|
|
|
11 |
5 |
p. e358-e367
|
artikel
|
| 3 |
Clotting and bleeding in Behçet's syndrome
|
Nair, Jagdish R
|
|
|
11 |
5 |
p. e390
|
artikel
|
| 4 |
Correction to Lancet Haematol 2024; 11: e216–27
|
|
|
|
11 |
5 |
p. e319
|
artikel
|
| 5 |
Diagnosis, treatment, and surveillance of Diamond-Blackfan anaemia syndrome: international consensus statement
|
Wlodarski, Marcin W
|
|
|
11 |
5 |
p. e368-e382
|
artikel
|
| 6 |
Diversity, equity, and inclusion in ASH guidelines
|
Seftel, Matthew D
|
|
|
11 |
5 |
p. e317
|
artikel
|
| 7 |
Diversity, equity, and inclusion in ASH guidelines – Authors’ reply
|
Jacobs, Jeremy W
|
|
|
11 |
5 |
p. e317-e318
|
artikel
|
| 8 |
Doggedly first-hand: a medical memoir that does not step outside itself
|
Lucas, Catherine
|
|
|
11 |
5 |
p. e320
|
artikel
|
| 9 |
First-line immunochemotherapy for extranodal natural killer/T cell lymphoma
|
Qi, Shu-Nan
|
|
|
11 |
5 |
p. e311-e313
|
artikel
|
| 10 |
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
|
Tian, Xiao-Peng
|
|
|
11 |
5 |
p. e336-e344
|
artikel
|
| 11 |
Methodological challenges in the development of endpoints for myelofibrosis clinical trials
|
Barosi, Giovanni
|
|
|
11 |
5 |
p. e383-e389
|
artikel
|
| 12 |
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
|
Stelljes, Matthias
|
|
|
11 |
5 |
p. e324-e335
|
artikel
|
| 13 |
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial
|
Gladwin, Mark T
|
|
|
11 |
5 |
p. e345-e357
|
artikel
|
| 14 |
Riociguat shows remarkable safety but underwhelming activity in patients with sickle cell disease
|
Limerick, Emily M
|
|
|
11 |
5 |
p. e313-e314
|
artikel
|
| 15 |
Sickle cell disease in India: current status and progress
|
Jain, Dipty
|
|
|
11 |
5 |
p. e322-e323
|
artikel
|
| 16 |
The value of anti-CD30 CAR T cells in Hodgkin lymphoma
|
Veyri, Marianne
|
|
|
11 |
5 |
p. e314-e316
|
artikel
|
| 17 |
Transplant without salvage: cut out the middleman
|
Law, Arjun Datt
|
|
|
11 |
5 |
p. e310-e311
|
artikel
|
| 18 |
Universal health coverage for children with cancer
|
The Lancet Haematology,
|
|
|
11 |
5 |
p. e309
|
artikel
|
Tijdschrift beschrijving